Stability of mild cognitive impairment in newly diagnosed Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 88, Issue 8, 2017, Pages 648-652

  Lawson, Rachael A ^a   Yarnall, Alison J ^a   Duncan, Gordon W ^a,b   Breen, David P ^c   Khoo, Tien K ^d,e   Williams Gray, Caroline H ^c   Barker, Roger A ^c   Burn, David J ^a   Rochester, Lynn ^a   Johnston, Fionnuala ^a   McDonald, Claire ^a   Sleeman, Isobel ^a   Chinnery, Patrick F ^a   O'Brien, John T ^f   Robbins, Trevor W ^f   Cummins, Gemma A ^c   Evans, Jonathan ^c   Brooks, David J ^g   Wesnes, Keith A ^h   Rowe, James B ⁱ  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d GRIFFITH UNIVERSITY   (Australia)

^e UNIVERSITY OF WOLLONGONG   (Australia)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

ⁱ Behavioural and Clinical Neuroscience Institute   (United Kingdom)

Author keywords

COGNITION; DEMENTIA; PARKINSON'S DISEASE

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE CLASSIFICATION; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MONTREAL COGNITIVE ASSESSMENT; MOVEMENT DISORDERS SOCIETY TASK FORCE LEVEL 1; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; AGED; COGNITIVE DYSFUNCTION; COHORT ANALYSIS; DISEASE COURSE; ENGLAND; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST;

AGED; COGNITIVE DYSFUNCTION; COHORT STUDIES; DEMENTIA; DISEASE PROGRESSION; ENGLAND; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 85024398283     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2016-315099     Document Type: Article

References (19)

1. Hely MA, Reid WG, Adena MA, et al. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008;23:837-44.
2. Litvan I, Goldman JG, Tröster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 2012;27:349-56.
3. Goldman JG, Holden S, Bernard B, et al. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease. Mov Disord 2013;28:1972-9.
4. Goldman JG, Holden S, Ouyang B, et al. Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests? Mov Disord 2015;30:402-6.
5. Koepsell TD, Gill DP, Chen B. Stability of clinical etiologic diagnosis in dementia and mild cognitive impairment: results from a multicenter longitudinal database. Am J Alzheimers Dis Other Demen 2013;28:750-8.
6. Yarnall AJ, Breen DP, Duncan GW, et al. Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology 2014;82:308-16.
7. Lawson R, Yarnall A, Duncan G, et al. Cognitive decline and quality of life in incident Parkinson's disease: the role of attention. Parkinsonism Relat Disord 2016;27:47-53.
8. Tomlinson CL, Stowe R, Patel S, et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649-53.
9. Nicholl CG, Lynch S, Kelly CA, et al. The cognitive drug research computerized assessment system in the evaluation of early dementia-is speed of the essence? Int J Geriatr Psychiatry 1995;10:199-206.
10. Robbins TW, James M, Owen AM, et al. Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia 1994;5:266-81.
11. Tombaugh TN, Kozak J, Rees L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol 1999;14:167-77.
12. Ala TA, Hughes LF, Kyrouac GA, et al. Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's disease. J Neurol Neurosurg Psychiatr 2001;70:483-8.
13. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-9.
14. Lawson RA, Yarnall AJ, Duncan GW, et al. Quality of life and mild cognitive impairment in early Parkinson's disease: does subtype matter? J Parkinsons Dis 2014;4:331-6.
15. Hoops S, Nazem S, Siderowf AD, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 2009;73:1738-45.
16. Burdick DJ, Cholerton B, Watson GS, et al. People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance. Mov Disord 2014;29:1258-64.
17. Santangelo G, Vitale C, Picillo M, et al. Mild cognitive impairment in newly diagnosed Parkinson's disease: a longitudinal prospective study. Parkinsonism Relat Disord 2015;21:1219-26.
18. Pedersen KF, Larsen JP, Tysnes OB, et al. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian Park West study. JAMA Neurol 2013;70:580-6.
19. Roberts RO, Knopman DS, Mielke MM, et al. Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. Neurology 2014;82:317-25.